Speakers discussed the disparities in prostate-specific antigen (PSA) screening rates among different racial groups and explored the potential of free PSA percentage as a predictive marker for future ...
Biochemical recurrence is when your PSA level starts to rise after finishing prostate cancer treatment, and it may sometimes indicate metastatic disease. Biochemical recurrence is a term for when your ...
This article was reviewed by Darragh O’Carroll, MD. Prostate-specific antigen (PSA) is a term you’ll probably become familiar with once you start getting screened regularly for prostate cancer ...
Dear Dr. Roach: I am a 68-year old male in good health who exercises regularly, doesn’t take any medications, and doesn’t have a family history of prostate cancer. During my most recent yearly ...
− Post-hoc analysis from Blue Earth Diagnostics’ Phase 3 SPOTLIGHT trial provides data about treatment planning, particularly when curative salvage therapy is considered – MONROE TOWNSHIP, N.J. & ...
Researchers recommend lowering it to 0.3-0.5 ng/mL per year when PSA level is below 4 ng/mL. ORLANDO—New findings presented here suggest clinicians should use a lower PSA velocity (PSAV) to recommend ...
Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on disease progression. Among patients with intermediate-risk prostate cancer, ...
Prostate biopsies based on PSA changes are largely unnecessary, researchers say. Feb. 25, 2010— -- If prostate biopsies were based only on the rate of change in PSA level over time, the number of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results